Podoplanin: a novel diagnostic immunohistochemical marker

August 11, 2006 | Comments Off on Podoplanin: a novel diagnostic immunohistochemical marker

Advances in Anatomic Pathology. 2006 Mar;13(2):83-8. [Link] Ordonez NG. University of Texas, Anderson Cancer Center, Houston, TX 77030, USA. nordonez@mdanderson.org Abstract Podoplanin is a transmembrane mucoprotein recognized by the recently…

Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro

August 11, 2006 | Comments Off on Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro

Oncology Research. 2006;16(2):85-95. [Link] Kano Y, Akutsu M, Tsunoda S, Izumi T, Kobayashi H, Inoue K, Mori K, Fujii H, Mano H, Odgerel T, Furukawa Y. Division of Hematology, Tochigi…

Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma

August 9, 2006 | Comments Off on Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma

Lung Cancer. 2006 Aug 4; [Epub ahead of print] [Link] Fischer JR, Ohnmacht U, Rieger N, Zemaitis M, Stoffregen C, Kostrzewa M, Buchholz E, Manegold C, Lahm H. Department of…

Malignant mesothelioma of the testes

August 1, 2006 | Comments Off on Malignant mesothelioma of the testes

Aktuelle Urologie. 2006 Jul;37(4):281-3. [Link] Hatzinger M, Hacker A, Langbein S, Grobholz R, Alken P. Urologische Universitatsklinik, Klinikum Mannheim gGmbH, Fakultat fur Klinische Medizin Mannheim der Ruprecht-Karls-Universitat Heidelberg. Abstract Introduction:…

Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000-2004

July 31, 2006 | Comments Off on Prophylactic examinations of workers formerly employed in asbestos processing plants: outcome of the Amiantus project in 2000-2004

Medycyna Pracy. 2006;57(2):101-8. [Link] Szubert Z, Stankiewicz-Choroszucha B, Wronska-Sobolewska M, Siewierska H, Kosinska M, Borys W, Jakubowski J, Wrobel R, Gazda U, Kedzierska B, Andrzejewski M, Sova M, Pawlowska-Koziell H,…

Histiocytoid eccrine sweat gland carcinoma of the eyelid: report of a case

July 28, 2006 | Comments Off on Histiocytoid eccrine sweat gland carcinoma of the eyelid: report of a case

Clinical and Experimental Dermatology. 2006 Jul 24; [Epub ahead of print] [Link] Swinson B, Ryan F, Barrett AW, Jerjes W, Landon G, Calonje E, Kalavrezos N. Oral and Maxillofacial Pathology…

p53-Induced Apoptosis Occurs in the Absence of p14(ARF) in Malignant Pleural Mesothelioma

July 27, 2006 | Comments Off on p53-Induced Apoptosis Occurs in the Absence of p14(ARF) in Malignant Pleural Mesothelioma

Neoplasia. 2006 Jul;8(7):551-9. [Link] Hopkins-Donaldson S, Belyanskaya AL, Simoes-Wust AP, Sigrist B, Kurtz S, Zangemeister-Wittke U, Stahel R. Laboratory for Molecular Oncology, University Hospital Zurich, Haeldeliweg 4, CH-8044 Zurich, Switzerland,…

Pleural Mesothelioma in a Woman Whose Documented Past Exposure to Asbestos was From Smoking Asbestos-Containing Filtered Cigarettes: The Comparative Value of Analytical Transmission Electron Microscopic Analysis of Lung and Lymph-Node Tissue

July 26, 2006 | Comments Off on Pleural Mesothelioma in a Woman Whose Documented Past Exposure to Asbestos was From Smoking Asbestos-Containing Filtered Cigarettes: The Comparative Value of Analytical Transmission Electron Microscopic Analysis of Lung and Lymph-Node Tissue

Inhalation Toxicology. 2006 Aug;18(9):679-84. [Link] Dodson RF, Hammar SP. Dodson Environmental Consulting, Inc., and ERI Analytical, Tyler, Texas, USA. Abstract Asbestos has had many commercial applications, including its use as…

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors

July 25, 2006 | Comments Off on Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors

Oncogene. 2006 Jul 24; [Epub ahead of print] [Link] Borczuk AC, Cappellini GC, Kim HK, Hesdorffer M, Taub RN, Powell CA. Department of Pathology, Columbia University College of Physicians &…

Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma

July 24, 2006 | Comments Off on Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma

Clinical Cancer Research. Vol. 12, 4225-4231, July 15, 2006. [Link] Masanori Onda1, Satoshi Nagata1, Mitchell Ho1, Tapan K. Bera1, Raffit Hassan1, Richard H. Alexander2 and Ira Pastan1 Authors’ Affiliations: 1…

Categories